Menu

Breast cancer

3,150 trials in this section

Recruiting NCT05795101

TRUDI: TDXD+Durva in HER2+/Low IBC

Phase II Interventional United States

Invasive Breast Cancer · Inflammatory Breast Cancer Stage III · HER2-positive Breast Cancer